Randomized PhaseII study of amrubicin vs platinum-doublet re-challenge for small cell lung cancer with sensitive relapse
Phase of Trial: Phase II
Latest Information Update: 15 Oct 2015
At a glance
- Drugs Amrubicin (Primary) ; Platinum complexes
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 23 Apr 2015 Status changed from active, no longer recruiting to completed.
- 31 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.